<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biomed Res Int</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biomed Res Int</journal-id>
      <journal-id journal-id-type="publisher-id">BMRI</journal-id>
      <journal-title-group>
        <journal-title>BioMed Research International</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2314-6133</issn>
      <issn pub-type="epub">2314-6141</issn>
      <publisher>
        <publisher-name>Hindawi Publishing Corporation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24900990</article-id>
      <article-id pub-id-type="pmc">4034395</article-id>
      <article-id pub-id-type="doi">10.1155/2014/827635</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>No Evidence for an Association of Vitamin D Deficiency and Migraine: A Systematic Review of the Literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9523-9054</contrib-id>
          <name>
            <surname>Lippi</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cervellin</surname>
            <given-names>Gianfranco</given-names>
          </name>
          <xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mattiuzzi</surname>
            <given-names>Camilla</given-names>
          </name>
          <xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="I1"><sup>1</sup>Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, 43126 Parma, Italy</aff>
      <aff id="I2"><sup>2</sup>U.O. Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, 14 Via Gramsci, 43126 Parma, Italy</aff>
      <aff id="I3"><sup>3</sup>Emergency Department, Academic Hospital of Parma, 43126 Parma, Italy</aff>
      <aff id="I4"><sup>4</sup>Service of Clinical Governance, General Hospital of Trento, 38122 Trento, Italy</aff>
      <author-notes>
        <corresp id="cor1">*Giuseppe Lippi: <email>glippi@ao.pr.it</email></corresp>
        <fn fn-type="other">
          <p>Academic Editor: Sebastian Straube</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <volume>2014</volume>
      <elocation-id>827635</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Giuseppe Lippi et al.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Vitamin D deficiency is associated with a number of human disorders, including cardiovascular disease, cancer, diabetes, frailty, and infections. Since an association between vitamin D and migraine has also been recently speculated, we performed an electronic search on Medline, Scopus, and Web of Science using the keywords &#x201C;migraine&#x201D; and &#x201C;vitamin D,&#x201D; &#x201C;25OH-D&#x201D; &#x201C;cholecalciferol,&#x201D; &#x201C;ergocalciferol,&#x201D; with no language or date restriction. The electronic search allowed identifying seven studies (3 observational, 2 cross-sectional, and 2 case reports). The two case reports, including four women, showed favourable effects of vitamin D supplementation on migraine severity, but these studies were small and not placebo controlled. As regards the three observational studies, vitamin D deficiency was observed in 13.2 to 14.8% of migraine patients, and these rates do not differ from those reported in the general population (i.e., vitamin D deficiency between 22 and 42%). The results of the two cross-sectional studies are even more controversial, since no association was found between vitamin D status and migraine in both trials. In conclusion, the current evidence suggests that the association between migraine and vitamin D lacks reliable scientific support.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>
The generic term &#x201C;vitamin D&#x201D; comprehends a number of fat-soluble secosteroids that exert a multitude of biological functions in vertebrates. In humans, the most important compounds are represented by ergocalciferol (i.e., vitamin D2) and cholecalciferol (i.e., vitamin D3) [<xref rid="B1" ref-type="bibr">1</xref>]. The former molecule is not constitutively produced by plants or vertebrates but mainly originates from phytoplankton, fungi, and invertebrates. At variance with ergocalciferol, cholecalciferol is actively synthesized in humans and can also be assumed with the diet by ingestion of animal sources, especially liver, fish, eggs, or yolks [<xref rid="B1" ref-type="bibr">1</xref>].</p>
      <p>The keratinocytes of the skin are the leading source of vitamin D in humans. In brief, previtamin D is synthesized nonenzymatically from 7-dehydrocholesterol during exposure to the UV rays and then undergoes a temperature-dependent rearrangement to generate cholecalciferol [<xref rid="B2" ref-type="bibr">2</xref>]. The synthesis of 25-hydroxyvitamin D (25OH-D) is typically dependent upon vitamin D hydroxylation in the liver, which is then followed by a further hydroxylation in the kidneys to generate 1-<italic>&#x3B1;</italic>,25-dihydroxycholecalciferol (i.e., calcitriol or 1,25OH-2D). According to this biologic pathway, the concentration of total vitamin D (i.e., 25OH-D) is currently regarded as the most suitable indicator of total vitamin D body stores [<xref rid="B3" ref-type="bibr">3</xref>].</p>
      <p>Besides the well-established function on bone metabolism [<xref rid="B4" ref-type="bibr">4</xref>], low levels of vitamin D have been recently implicated in a number of human disorders, including cardiovascular disease [<xref rid="B5" ref-type="bibr">5</xref>], cancer [<xref rid="B6" ref-type="bibr">6</xref>], diabetes [<xref rid="B7" ref-type="bibr">7</xref>], frailty [<xref rid="B8" ref-type="bibr">8</xref>], and infections [<xref rid="B9" ref-type="bibr">9</xref>]. Interestingly, an association between vitamin D concentration and migraine has also been recently speculated by Prakash et al., who reported an increased frequency of headache attacks in autumn-winter and a reduced frequency in summer, a trend that closely mirrors the seasonal variations of serum vitamin D levels [<xref rid="B10" ref-type="bibr">10</xref>]. Migraine is a highly prevalent condition, which is currently ranked third among the most frequent human diseases and seventh among the leading causes of disability worldwide [<xref rid="B11" ref-type="bibr">11</xref>]. The pathogenesis of this condition is complex and multifaceted and basically involves an initial decrease of cerebral blood flow, which is then followed by reactive vasodilatation, plasma protein extravasation, and sterile inflammation in association with hypersensitization of central pain pathways [<xref rid="B12" ref-type="bibr">12</xref>]. Recent evidence also suggests that migraine with or without aura shares similar pathogenetic and clinical aspects, wherein the aura of migraine cannot be biologically disconnected from the actual headache attack [<xref rid="B13" ref-type="bibr">13</xref>].</p>
      <p>As such, the aim of this paper is to provide an overview of the current scientific literature about the potential epidemiological association between serum vitamin D and migraine.</p>
    </sec>
    <sec id="sec2">
      <title>2. Search Criteria</title>
      <p>We performed an electronic search on Medline, Scopus, and Web of Science using the keywords &#x201C;migraine&#x201D; and &#x201C;vitamin D,&#x201D; &#x201C;25OH-D,&#x201D; &#x201C;cholecalciferol,&#x201D; or &#x201C;ergocalciferol&#x201D; in the fields &#x201C;title,&#x201D; &#x201C;abstract,&#x201D; &#x201C;text,&#x201D; and &#x201C;MeSH (medical subject headings)&#x201D; or &#x201C;keywords,&#x201D; without applying language or date restriction. The bibliographic references of the items retrieved by the original search were also reviewed for identifying other pertinent investigations. Only those studies using standardized criteria for diagnosing migraine (e.g., those of the Headache Classification Committee of the International Headache Society) [<xref rid="B14" ref-type="bibr">14</xref>] and reporting original information about vitamin D status in migraine patients were finally included.</p>
    </sec>
    <sec id="sec3">
      <title>3. Overview on Epidemiological Data </title>
      <p>The electronic search performed according to the previously defined criteria produced 15 items after exclusion of duplicates across the different scientific databases. Accurate reading of title, abstract, and full text (when available) allowed the exclusion of 8 items, which did not report original information about vitamin D status in patients with migraine (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Seven studies were finally included in this systematic review, 3 observational, 2 cross-sectional, and 2 case reports (<xref ref-type="table" rid="tab1">Table 1</xref>) [<xref rid="B15" ref-type="bibr">15</xref>&#x2013;<xref rid="B21" ref-type="bibr">21</xref>].</p>
      <p>Thys-Jacobs originally described the cases of two premenopausal women with migraine and low levels of total serum vitamin D (19.8&#x2009;ng/mL and 15&#x2009;ng/mL), who were treated with a combination of vitamin D and calcium for the presence of late luteal phase symptoms [<xref rid="B15" ref-type="bibr">15</xref>]. In both cases, the therapy with calcium and vitamin D was associated with substantial reduction of migraine attacks within 2 months of therapy. In a case report, the same author reported the cases of two postmenopausal women with migraine and low serum vitamin D levels (i.e., &lt;5&#x2009;ng/mL and 17&#x2009;ng/mL), who were also treated with combination of vitamin D (1,200&#x2013;1,600&#x2009;IU daily) and calcium and displayed a considerable alleviation of both frequency and duration of migraine attacks [<xref rid="B16" ref-type="bibr">16</xref>]. These anecdotal reports paved the way to a subsequent series of studies, which directly investigated the potential relationship existing between vitamin D status and migraine.</p>
      <p>Wheeler systematically reviewed records from 54 consecutive chronic migraine patients (48 women and 6 men; age range 17&#x2013;73 years), who had serum vitamin D measured [<xref rid="B17" ref-type="bibr">17</xref>]. Vitamin D insufficiency (&#x2264;30&#x2009;ng/mL) and deficiency (&#x2264;20&#x2009;ng/mL) were observed in 40.7% and 14.8% of patients, respectively.</p>
      <p>In a cross-sectional study, Kjaergaard et al. assessed vitamin D status in 248 nonsmoker migraine patients (184 females and 64 males; mean age 50 &#xB1; 11 years) and in 6121 nonsmoker control subjects without migraine (2820 females and 3301 males; mean age 60 &#xB1; 12 years) [<xref rid="B18" ref-type="bibr">18</xref>]. The concentration of total serum vitamin D was found to be marginally but significantly lower in cases than in controls (21.2 &#xB1; 6.5 versus 22.4 &#xB1; 7.2&#x2009;ng/mL; <italic>P</italic> &lt; 0.05). In the same study, the authors assessed total vitamin D status in 74 smoker migraineurs (54 females and 20 males; mean age 49 &#xB1; 10 years) and in 1432 nonsmoker control subjects without migraine (686 females and 746 males; mean age 57 &#xB1; 12 years) but failed to find any significant difference between cases and controls (28.1 &#xB1; 11.2 versus 27.6 &#xB1; 8.2&#x2009;ng/mL; <italic>P</italic> = ns). Accordingly, in multivariable logistic regression analysis, no significant association was found between migraine and total serum vitamin D in both smokers (OR, 1.21; 95% CI, 0.57&#x2013;2.55) and nonsmokers (OR, 1.03; 95% CI, 0.67&#x2013;1.57).</p>
      <p>Khorvash et al. investigated vitamin D status in 66 migraine patients (49 women and 17 men; mean age 36 &#xB1; 9 years) [<xref rid="B19" ref-type="bibr">19</xref>]. Vitamin D insufficiency (12&#x2013;30&#x2009;ng/mL) and deficiency (&lt;12&#x2009;ng/mL) were recorded in 66.7% and 13.6% of patients, respectively. In an investigation by the same team of authors, vitamin D status was assessed in 76 migraine patients (55 women and 21 men; mean age 33 &#xB1; 11 years) [<xref rid="B20" ref-type="bibr">20</xref>]. In agreement with previous data, vitamin D insufficiency (12&#x2013;30&#x2009;ng/mL) and deficiency (&lt;12&#x2009;ng/mL) were observed in 68.4% and 13.2% of patients, respectively.</p>
      <p>Finally, Zandifar et al. performed a cross-sectional investigation including 105 patients with migraine (80 females and 25 males; mean age 33 &#xB1; 1 years) and 110 healthy controls (89 females and 21 males; mean age 32 &#xB1; 1 years) [<xref rid="B21" ref-type="bibr">21</xref>]. No significant difference was observed in the concentration of total serum vitamin D between cases and controls (13.6 &#xB1; 0.9 versus 13.2 &#xB1; 1.2&#x2009;ng/mL; <italic>P</italic> = ns). The prevalence of vitamin D insufficiency (10&#x2013;20&#x2009;ng/mL) and deficiency (&lt;10&#x2009;ng/mL) was also similar between cases and controls (insufficiency: 34.3% versus 30.0%, <italic>P</italic> = ns; deficiency: 45.7% versus 51.8%; <italic>P</italic> = ns). Interestingly, no significant association was also observed between vitamin D concentration and frequency of migraine attacks, duration of migraine attacks, and positive family history of migraine.</p>
    </sec>
    <sec id="sec4">
      <title>4. Conclusions</title>
      <p>Due to the high prevalence and the substantial clinical and economical burden placed on society, migraine should now be regarded as a public healthcare issue [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B22" ref-type="bibr">22</xref>]. The current approach for prevention of episodic migraine, as recently endorsed by the American Headache Society (AHS) and the American Academy of Neurology (AAN), is based on administration of topiramate, divalproex/sodium valproate, propranolol, and metoprolol [<xref rid="B23" ref-type="bibr">23</xref>]. Among nutritional supplements classified as &#x201C;probably effective,&#x201D; only riboflavin (i.e., vitamin B2) is included in the AHS/AAN guidelines. As regards the therapy of migraine, the AAN evidence-based guidelines currently advocate the use of specific agents (e.g., triptans or dihydroergotamine) in patients with moderate migraine and nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin plus acetaminophen in those with mild-to-moderate migraine attacks [<xref rid="B24" ref-type="bibr">24</xref>]. Even in this case, however, riboflavin was the only nutritional supplement for which an acceptable scientific support was acceptable.</p>
      <p>Taken together, the current scientific evidence in support of a putative relationship between vitamin D deficiency and migraine is largely unsubstantial. The two separate case reports, including 4 women, showed a favourable effect of vitamin D supplementation on migraine severity, but these were obviously small studies and not placebo controlled. As regards the observational investigations, the frequency of vitamin D deficiency was found to be comprised between 13.2% and 14.8% of all migraine patients (<xref ref-type="table" rid="tab1">Table 1</xref>). It is noteworthy that the burden of vitamin D deficiency in the general population ranges from 22% to 42% across different ages and genders [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>], and these figures are not really different from those reported in patients with migraine. The results of the two cross-sectional studies are even more controversial. In one of these, neither the concentration of total serum vitamin D nor the prevalence of vitamin D deficiency was found to be significantly different between controls and patients with migraine [<xref rid="B21" ref-type="bibr">21</xref>]. In the other study, a significant association between serum levels of vitamin D was found in nonsmokers but not in smokers [<xref rid="B20" ref-type="bibr">20</xref>]. It is noteworthy, however, that the significance of this modest association was completely lost after adjustment for age, body mass index, education level, alcohol consumption, and physical exercise, thus confirming that no apparent relationship exists between total serum vitamin D levels and migraine.</p>
      <p>Among the studies that have been excluded from this systematic review due to the lack of data about serum vitamin D levels, one deserves special mention. Motaghi et al. assessed the relationship between two vitamin D receptor (VDR) gene polymorphisms (i.e., TaqI f/F and FokI t/T) and migraine in a cross-sectional study including 103 patients with episodic migraine (85 females and 18 males; mean age 34 &#xB1; 1 years) and 100 healthy nonmigraineurs (78 females and 22 males; mean age 35 &#xB1; 1 years) [<xref rid="B27" ref-type="bibr">27</xref>]. Interestingly, both heterozygote genotypes were significantly more prevalent in migraine patients than in controls (OR 1.81; 95% CI 1.03&#x2013;3.18; <italic>P</italic> = 0.02 for TaqI and OR, 2.91; 95% CI, 1.47&#x2013;5.77; <italic>P</italic> = 0.001 for FokI, resp.). Although these interesting findings do not provide definitive evidence for a causal association between VDR gene and migraine, the VDR has a broad expression in the central nervous system, where the binding to its agonists produces an important (pleiotropic) anti-inflammatory effect [<xref rid="B28" ref-type="bibr">28</xref>]. Since neurogenic inflammation is an essential part of migraine pathogenesis [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>], further studies are indeed advisable to establish whether the interplay between VDR agonists and VDR gene polymorphisms may have a role in preventing the development or worsening of migraine attacks.</p>
      <p>The demand for vitamin D testing is dramatically increasing worldwide, often inappropriately [<xref rid="B29" ref-type="bibr">29</xref>]. The results of our analysis of clinical trials that have investigated the association between migraine and total serum vitamin D suggest that this relationship lacks reliable scientific support, so that this condition does not represent a valid indication for testing. Although larger cross-sectional or randomized prospective trials are obviously needed to draw definitive conclusions, vitamin D supplementation for prevention or treatment of migraine seems also unadvisable at this point in time. This is noteworthy, since the notion that vitamin D supplementation is absolutely safe has been recently challenged, especially in the elderly [<xref rid="B30" ref-type="bibr">30</xref>].</p>
    </sec>
  </body>
  <back>
    <sec sec-type="conflict">
      <title>Conflict of Interests</title>
      <p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p>
    </sec>
    <sec>
      <title>Authors' Contribution</title>
      <p>Giuseppe Lippi and Camilla Mattiuzzi had substantial contributions to the conception and design of the study and data collection and analysis. They also contributed to the drafting of the paper. Gianfranco Cervellin had substantial contributions to the conception and design of the study and the drafting of the paper.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holick</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Medical progress: v itamin D deficiency</article-title>
          <source>
            <italic>The New England Journal of Medicine</italic>
          </source>
          <year>2007</year>
          <volume>357</volume>
          <issue>3</issue>
          <fpage>266</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="other">2-s2.0-34447514029</pub-id>
          <pub-id pub-id-type="pmid">17634462</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bikle</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D metabolism and function in the skin</article-title>
          <source>
            <italic>Molecular and Cellular Endocrinology</italic>
          </source>
          <year>2011</year>
          <volume>347</volume>
          <issue>1-2</issue>
          <fpage>80</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="other">2-s2.0-82455162446</pub-id>
          <pub-id pub-id-type="pmid">21664236</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrmann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The measurement of 25-hydroxy vitamin D&#x2014;an analytical challenge</article-title>
          <source>
            <italic>Clinical Chemistry and Laboratory Medicine</italic>
          </source>
          <year>2012</year>
          <volume>50</volume>
          <fpage>1873</fpage>
          <lpage>1875</lpage>
          <pub-id pub-id-type="pmid">23113976</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christodoulou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goula</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ververidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Drosos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>&#x201C;</surname>
            </name>
          </person-group>
          <article-title>Vitamin D and bone disease</article-title>
          <source>
            <italic>BioMed Research International</italic>
          </source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>6 pages</fpage>
          <pub-id pub-id-type="publisher-id">396541</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Targher</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pichiri</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lippi</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D, thrombosis, and hemostasis: more than skin deep</article-title>
          <source>
            <italic>Seminars in Thrombosis and Hemostasis</italic>
          </source>
          <year>2012</year>
          <volume>38</volume>
          <issue>1</issue>
          <fpage>114</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="other">2-s2.0-84857017590</pub-id>
          <pub-id pub-id-type="pmid">22314609</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teleni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koczwara</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical outcomes of vitamin D deficiency and supplementation in cancer patients</article-title>
          <source>
            <italic>Nutrition Reviews</italic>
          </source>
          <year>2013</year>
          <volume>71</volume>
          <fpage>611</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="pmid">24032365</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitri</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Muraru</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Pittas</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D and type 2 diabetes: a systematic review</article-title>
          <source>
            <italic>European Journal of Clinical Nutrition</italic>
          </source>
          <year>2011</year>
          <volume>65</volume>
          <issue>9</issue>
          <fpage>1005</fpage>
          <lpage>1015</lpage>
          <pub-id pub-id-type="other">2-s2.0-80052600114</pub-id>
          <pub-id pub-id-type="pmid">21731035</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lippi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sanchis-Gomar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Montagnana</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Biological markers in older people at risk of mobility limitations</article-title>
          <comment><italic>Current Pharmaceutical Design</italic>. In press</comment>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macaluso</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Maida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Minissale</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Metabolic factors and chronic hepatitis C: a complex interplay</article-title>
          <source>
            <italic>BioMed Research International</italic>
          </source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>12 pages</fpage>
          <pub-id pub-id-type="publisher-id">564645</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prakash</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Dabhi</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Lakhani</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Khilari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>The prevalence of headache may be related with the latitude: a possible role of Vitamin D insufficiency?</article-title>
          <source>
            <italic>The Journal of Headache and Pain</italic>
          </source>
          <year>2010</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>301</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="other">2-s2.0-79953047113</pub-id>
          <pub-id pub-id-type="pmid">20464624</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steiner</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Stovner</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Birbeck</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Migraine: the seventh disabler</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>2013</year>
          <volume>53</volume>
          <fpage>227</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">23317094</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goadsby</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Cortical spreading depression&#x2014;better understanding and more questions. Focus on &#x2018;distinct vascular conduction with cortical spreading depression&#x2019;</article-title>
          <source>
            <italic>Journal of Neurophysiology</italic>
          </source>
          <year>2007</year>
          <volume>97</volume>
          <issue>6</issue>
          <fpage>p. 3827</fpage>
          <pub-id pub-id-type="other">2-s2.0-34447519219</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Purdy</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Migraine with and without aura share the same pathogenic mechanisms</article-title>
          <source>
            <italic>Neurological Sciences</italic>
          </source>
          <year>2008</year>
          <volume>29</volume>
          <issue>supplement 1</issue>
          <fpage>S44</fpage>
          <lpage>S46</lpage>
          <pub-id pub-id-type="other">2-s2.0-45249111362</pub-id>
          <pub-id pub-id-type="pmid">18545895</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <collab>Headache Classification Committee of the International Headache Society (IHS)</collab>
          <article-title>The international classification of headache ddisorders</article-title>
          <source>
            <italic>Cephalalgia</italic>
          </source>
          <year>2013</year>
          <volume>33</volume>
          <edition>3rd edition</edition>
          <fpage>629</fpage>
          <lpage>808</lpage>
          <pub-id pub-id-type="pmid">23771276</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thys-Jacobs</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D and calcium in menstrual migraine</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>1994</year>
          <volume>34</volume>
          <issue>9</issue>
          <fpage>544</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="other">2-s2.0-0028028320</pub-id>
          <pub-id pub-id-type="pmid">8002332</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thys-Jacobs</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Alleviation of migraines with therapeutic vitamin D and calcium</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>1994</year>
          <volume>34</volume>
          <issue>10</issue>
          <fpage>590</fpage>
          <lpage>592</lpage>
          <pub-id pub-id-type="other">2-s2.0-0028063212</pub-id>
          <pub-id pub-id-type="pmid">7843955</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wheeler</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D deficiency in chronic migraine</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>2008</year>
          <volume>48</volume>
          <issue>supplement 1</issue>
          <fpage>S52</fpage>
          <lpage>S53</lpage>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kjaergaard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eggen</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Mathiesen</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Jorde</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Association between headache and serum 25-hydroxyvitamin D; the Troms&#xF8; Study: Troms&#xF8; 6</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>1499</fpage>
          <lpage>1505</lpage>
          <pub-id pub-id-type="pmid">22973803</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khorvash</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mottaghi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Askari</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The association between serum vitamin d levels with general and abdominal obesity among patients with migraine</article-title>
          <source>
            <italic>International Journal of Preventive Medicine</italic>
          </source>
          <year>2013</year>
          <volume>4</volume>
          <issue>supplement 2</issue>
          <fpage>S313</fpage>
          <lpage>S317</lpage>
          <pub-id pub-id-type="pmid">23776744</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mottaghi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Khorvash</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Askari</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The relationship between serum levels of vitamin D and migraine</article-title>
          <source>
            <italic>Journal of Research in Medical Sciences</italic>
          </source>
          <year>2013</year>
          <volume>18</volume>
          <issue>supplement 1</issue>
          <fpage>S66</fpage>
          <lpage>S70</lpage>
          <pub-id pub-id-type="pmid">23961291</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zandifar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Masjedi</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Banihashemi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vitamin d status in migraine patients: a case-control study</article-title>
          <source>
            <italic>BioMed Research International</italic>
          </source>
          <year>2014</year>
          <volume>2014</volume>
          <pub-id pub-id-type="publisher-id">514782</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vos</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Flaxman</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Naghavi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title>
          <source>
            <italic>The Lancet</italic>
          </source>
          <year>2012</year>
          <volume>380</volume>
          <fpage>2163</fpage>
          <lpage>2196</lpage>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loder</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rizzoli P</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines</article-title>
          <source>
            <italic>Headache</italic>
          </source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>930</fpage>
          <lpage>945</lpage>
          <pub-id pub-id-type="pmid">22671714</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silberstein</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Edlund</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology</article-title>
          <source>
            <italic>Neurology</italic>
          </source>
          <year>2000</year>
          <volume>55</volume>
          <issue>6</issue>
          <fpage>754</fpage>
          <lpage>762</lpage>
          <pub-id pub-id-type="other">2-s2.0-0034718464</pub-id>
          <pub-id pub-id-type="pmid">10993991</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forrest</surname>
              <given-names>KYZ</given-names>
            </name>
            <name>
              <surname>Stuhldreher</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and correlates of vitamin D deficiency in US adults</article-title>
          <source>
            <italic>Nutrition Research</italic>
          </source>
          <year>2011</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>48</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="other">2-s2.0-79551638426</pub-id>
          <pub-id pub-id-type="pmid">21310306</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lippi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Montagnana</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meschi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Borghi L</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D concentration and deficiency across different ages and genders</article-title>
          <source>
            <italic>Aging Clinical and Experimental Research</italic>
          </source>
          <year>2012</year>
          <volume>24</volume>
          <fpage>548</fpage>
          <lpage>551</lpage>
          <pub-id pub-id-type="pmid">22314303</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motaghi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haghjooy Javanmard</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haghdoost</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Relationship between vitamin D receptor gene polymorphisms and migraine without aura in an Iranian population</article-title>
          <source>
            <italic>BioMed Research International</italic>
          </source>
          <year>2013</year>
          <volume>2013</volume>
          <pub-id pub-id-type="publisher-id">351942</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scolletta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Colletti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Di Luigi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Crescioli</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation</article-title>
          <source>
            <italic>Mediators of Inflammation</italic>
          </source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>11 pages</fpage>
          <pub-id pub-id-type="publisher-id">876319</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieth</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The future of &#x201C;vitamin D&#x201D;, i.e. 25-hydroxyvitamin D, testing</article-title>
          <source>
            <italic>Clinical Biochemistry</italic>
          </source>
          <year>2013</year>
          <volume>46</volume>
          <fpage>p. 189</fpage>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geddes</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Inderjeeth</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Evidence for the treatment of osteoporosis with vitamin d in residential care and in the community dwelling elderly</article-title>
          <source>
            <italic>BioMed Research International</italic>
          </source>
          <year>2013</year>
          <volume>2013</volume>
          <pub-id pub-id-type="publisher-id">463589</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Flow diagram of study selection about the association between total serum vitamin D values and migraine.</p>
      </caption>
      <graphic xlink:href="BMRI2014-827635.001"/>
    </fig>
    <table-wrap id="tab1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Synthesis of epidemiological studies exploring the association between vitamin D and migraine.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">Author</th>
            <th align="left" rowspan="1" colspan="1">Study design</th>
            <th align="center" rowspan="1" colspan="1">Study population</th>
            <th align="left" rowspan="1" colspan="1">Outcome</th>
            <th align="center" rowspan="1" colspan="1">Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">Thys-Jacobs, 1994</td>
            <td align="left" rowspan="1" colspan="1">Case report</td>
            <td align="center" rowspan="1" colspan="1">2 premenopausal women with migraine</td>
            <td align="left" rowspan="1" colspan="1">Migraine attenuation after therapy with vitamin D</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B15" ref-type="bibr">15</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Thys-Jacobs, 1994</td>
            <td align="left" rowspan="1" colspan="1">Case report</td>
            <td align="center" rowspan="1" colspan="1">2 postmenopausal women with migraine</td>
            <td align="left" rowspan="1" colspan="1">Migraine attenuation after therapy with vitamin D</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B16" ref-type="bibr">16</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Wheeler, 2008</td>
            <td align="left" rowspan="1" colspan="1">Observational</td>
            <td align="center" rowspan="1" colspan="1">54 migraine patients</td>
            <td align="left" rowspan="1" colspan="1">Vitamin D insufficiency or deficiency observed in 40.7% and 14.8% of patients</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B17" ref-type="bibr">17</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Kjaergaard et al., 2012</td>
            <td align="left" rowspan="1" colspan="1">Cross-sectional</td>
            <td align="center" rowspan="1" colspan="1">248 nonsmoker migraine patients and 6121 controls; 74 smoker migraine patients and 1432 controls</td>
            <td align="left" rowspan="1" colspan="1">Serum vitamin D marginally lower in cases than in controls in nonsmokers but not in smokers</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">
Khorvash et al., 2013</td>
            <td align="left" rowspan="1" colspan="1">Observational</td>
            <td align="center" rowspan="1" colspan="1">66 migraine patients</td>
            <td align="left" rowspan="1" colspan="1">Vitamin D insufficiency or deficiency observed in 66.7% and 13.6% of patients</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Mottaghi et al., 2013</td>
            <td align="left" rowspan="1" colspan="1">Observational</td>
            <td align="center" rowspan="1" colspan="1">76 migraine patients</td>
            <td align="left" rowspan="1" colspan="1">Vitamin D insufficiency or deficiency observed in 68.4% and 13.2% of patients</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B20" ref-type="bibr">20</xref>]</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Zandifar et al., 2014</td>
            <td align="left" rowspan="1" colspan="1">Cross-sectional</td>
            <td align="center" rowspan="1" colspan="1">105 migraine patients and 110 controls</td>
            <td align="left" rowspan="1" colspan="1">Serum vitamin D not significantly different between cases and controls</td>
            <td align="center" rowspan="1" colspan="1">[<xref rid="B21" ref-type="bibr">21</xref>]</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
